ASX 200 afternoon report: 17 October 2023
Your ASX 200 afternoon report
The ASX 200 trades 31 points (0.44%) higher at 7057 at 3.20 pm AEDT.
The ASX 200 trades 31 points (0.44%) higher at 7057 at 3.20 pm AEDT.
ASX 200 decreases after RBA’s meeting
After a blistering 1% rally to start today's session, the ASX 200 has trimmed a good chunk of its gains after more hawkish than-expected RBA meeting minutes.
RBA board members under new Governor Michele Bullock, noting that the "Board has a low tolerance for a slower return of inflation to target than currently expected" and that "further tightening of policy may be required should inflation prove more persistent than expected."
We have consistently noted that after last month's robust labour force report, we thought the chance of one more 25bp rate hike to 4.35% before year-end was underpriced.
Q3 inflation report
Whether a hotter-than-expected Q3 inflation report next Wednesday, sees the RBA deliver an unwelcome Melbourne Cup Day rate rise surprise, will depend on how geopolitical events in the Middle East play out over the next three weeks.
If tensions in the Middle East were to escalate between now and then, talk of a rate hike could be replaced with conversations around rate cuts.
Today's market movement
IT sector
Returning to markets, the IT sector has rebounded, taking its lead from the Nasdaq, which locked in a 1.18% to start the week.
- ZIP: +7.14% to $0.30c
- EML Payments: + 4.23% to $1.11
- Megaport: + 4.25% to $11.53
- Block: + 2.66% to $70.72
Resources sector
Chatter around further Chinese stimulus measures to be unveiled in the coming weeks helped by iron ore price add 2.59% overnight to $117.25 per tonne.
- Mineral Resources: + 2% to $63.53
- Rio Tinto: + 1.68% to $117.66
- BHP gained 1.33% to $45.78
- Fortescue: + 1.3% to $21.82
Banking sector
- Macquarie: + 0.73% to $168.93
- Westpac: + 0.73% to $21.46
- NAB: + 0.69% to $29.33
- CBA: 0.35% to $101.04
Consumer-facing stocks have fallen on talk that the RBA has unfinished business hiking rates.
- Harvey Norman: - 2.12% to $3.69
- Myer: - 1.9% to $0.51c,
- Super Retail Group: -1.3% to $$12.13
- JB Hi-Fi: - 1.28% to $45.90.
Healthcare sector
The ASX 200 healthcare sector, which fell to a three-and-a-half-year low yesterday, stumbled again.
- Telix Pharma: - 1.25% to $10.28
- Pro Medicus: - 1% to $81.42
- Bionic ear company Cochlear: - 0.71% to $253.28
- Biotech giant CSL: - 0.59% to $238.42
ASX 200 technical analysis
In late September, we turned tactically bullish on the ASX 200 (just above 7000), looking for a rebound towards range (7440) highs and possibly year-to-date highs (7567). Stops on the bullish view are a sustained close below 6900/70ish.
ASX 200 daily chart
TradingView: the figures stated are as of October 17, 2023. Past performance is not a reliable indicator of future performance. This report does not contain and is not to be taken as containing any financial product advice or financial product recommendation.
IGA, may distribute information/research produced by its respective foreign affiliates within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.
The information/research herein is prepared by IG Asia Pte Ltd (IGA) and its foreign affiliated companies (collectively known as the IG Group) and is intended for general circulation only. It does not take into account the specific investment objectives, financial situation, or particular needs of any particular person. You should take into account your specific investment objectives, financial situation, and particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit.
No representation or warranty is given as to the accuracy or completeness of this information. Consequently, any person acting on it does so entirely at their own risk. Please see important Research Disclaimer.
Please also note that the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.
Live prices on most popular markets
- Forex
- Shares
- Indices
See more forex live prices
See more shares live prices
Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.
See more indices live prices
Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 20 mins.